A phase II study of repetitive cycles of dose-intense carboplatin plus paclitaxel chemotherapy and peripheral blood stem cells in metastatic breast cancer

Seminars in Oncology

Volumn 24, Issue 5 SUPPL. 17, 1997, Pages

  Ford, C ^a   Spitzer, G ^a   Reilly, W ^a   Adkins, D ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL; ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

BLOOD TOXICITY; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; ADULT; ARTICLE; BREAST TUMOR; DRUG ADMINISTRATION; FEASIBILITY STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARBOPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PACLITAXEL;

EID: 0031256076     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)